Leerink Partnrs Has Bullish Forecast for AXSM Q2 Earnings
Axsome Therapeutics, Inc. (NASDAQ:AXSM – Free Report) – Leerink Partnrs upped their Q2 2025 earnings per share (EPS) estimates for Axsome Therapeutics in a note issued to investors on Monday, May 5th. Leerink Partnrs analyst M. Goodman now expects that the company will post earnings of ($1.21) per share for the quarter, up from their […]
Axsome Therapeutics, Inc. (NASDAQ:AXSM – Free Report) – Leerink Partnrs upped their Q2 2025 earnings per share (EPS) estimates for Axsome Therapeutics in a note issued to investors on Monday, May 5th. Leerink Partnrs analyst M. Goodman now expects that the company will post earnings of ($1.21) per share for the quarter, up from their […]
